5th TCR-based Therapies for Solid Tumors Summit 2024
Evvnt Promotion / evvnt
Archivo
23.04.2024 - 25.04.2024 Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 9:00 AM - 5:30 PM
Temas de la conferencia
Our core commitment centers on advancing R and D and Clinical Development strategies for TCR therapies, aiming to harness their immense potential in targeting solid tumors. These therapies offer promising avenues for enhancing treatment methodologies, thereby fostering optimism for improved outcomes among patients grappling with these challenging conditions.
Our core commitment centers on advancing R and D and Clinical Development strategies for TCR therapies, aiming to harness their immense potential in targeting solid tumors. These therapies offer promising avenues for enhancing treatment methodologies, thereby fostering optimism for improved outcomes among patients grappling with these challenging conditions.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/2147535-3?pid=4832
Speakers: Alfred Lim, Head of Pipeline Research, Etcembly, Andrew Bayliffe, Chief Scientific Officer, Marengo Therapeutics, Cagan Gurer, Vice President Disovery, TScan Therapeutics, and more
Brochure: https://go.evvnt.com/2147535-3?pid=4832
Speakers: Alfred Lim, Head of Pipeline Research, Etcembly, Andrew Bayliffe, Chief Scientific Officer, Marengo Therapeutics, Cagan Gurer, Vice President Disovery, TScan Therapeutics, and more
Información e inscripción:
https://go.evvnt.com/2147535-2?pid=4832
Ms. Kate Woodford
Medicina General
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
